News
[PUBLICATION] The NMDA receptor modulator zelquistinel durably relieves behavioral deficits in three mouse models of autism spectrum disorder.
![](https://ibrain.univ-tours.fr/medias/photo/fonteneau2024_1709023589807-PNG)
Dates
from February 27, 2024 to March 26, 2024
A publication by Mathieu Fonteneau, Jerôme Becker and Julie Le Merrer in Neuropharmacology, in collaboration with the USA.